Scientists construct precise arrays of virus particles toward more efficient diagnostic assays

Figure 1: Electron microscopy image of measles virus particles firmly attached to the surface of a slide with a photoreactive polymer. Credit: Sivakumar et al.

Antibodies in the bloodstream hold the history of a patient's past infections. Clinicians probe this history by immobilizing protein particles or proteins of clinical interest onto the plastic surface of an assay plate and looking for antibodies that 'stick' to those targets after incubation with a serum sample. Yoshihiro Ito and colleagues from the RIKEN Center for Emergent Matter Science have now devised a superior assay that allows researchers and clinicians to obtain such diagnostic information more efficiently.

For some time now, scientists have been detecting DNA using 'microarrays'—glass slides featuring immense numbers of precisely positioned spots, each containing a different target sequence of interest. Unfortunately, translating this approach for has been problematic. "DNA is made of only four bases and the range of chemical functional groups is very limited," says Ito. "But proteins are composed of 20 amino acids with many chemical , which makes it difficult to immobilize different proteins on the same surface using a single method."

Ito and his colleagues found some success with photo-immobilization, in which proteins are mixed with polymers that essentially turn into 'glue' when bombarded with ultraviolet (UV) light. However, as existing polymers are poorly suited for whole virus particles, the team embarked on a search for a superior photo-immobilization medium. The search pointed to photoreactive polyethylene glycol (PEG), which offers numerous advantages. Notably, PEG forms a layer on the slide surface that resists binding by nontarget molecules, thereby yielding more accurate assay results. PEG also responds to lower levels of irradiation, minimizing the risk of UV damage to bound proteins or viruses.

After confirming that the photoreactive PEG layer can successfully affix (Fig. 1), the researchers developed an automated workflow that enabled them to analyze antibody binding from tiny volumes of patient serum on a microarray in just 20 minutes. By comparison, a standard plate-based assay requires far more serum and takes a few hours to complete. The tests also showed essentially equivalent performances in analyzing patient for five different viruses, with a false-negative rate lower than 5 per cent in most cases.

The system is now undergoing further development with the RIKEN venture company Consonal Biotechnologies and Ito sees great potential for rapidly testing a larger number of samples against a greater number of targets. "Our system achieves short detection times with small amounts of blood," he says. "We hope to contribute to society by commercializing this useful system."

More information: Sivakumar, P. M., Moritsugu, N., Obuse, S., Isoshima, T., Tashiro, H. & Ito, Y. "Novel microarrays for simultaneous serodiagnosis of multiple antiviral antibodies." PLoS ONE 8, e81726 (2013). dx.doi.org/10.1371/journal.pone.0081726

add to favorites email to friend print save as pdf

Related Stories

Improving human immunity to malaria

Aug 01, 2012

The deadliest form of malaria is caused the protozoan Plasmodium falciparum. During its life-cycle in human blood, the parasite P. falciparum expresses unique proteins on the surface on infected blood cells. ...

Probing changes to infant milk formulations

Jan 22, 2014

Infant milk formula is a widely accepted alternative to breast milk for babies in their first year of life. Since breast milk contains all the nutrients required by young infants, formula manufacturers aim ...

Recommended for you

Growing a blood vessel in a week

14 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

17 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments